CPL @1095 (98.6%) on 17-jan-2018 [ "_ is highly protein" "Geriatric Use Clinical studies of _" "Patients taking _" "drug interactions between _" "Use Clinical studies of _" "combination therapy including _" "patient was treated with _" "period patient was treated with _" "same period patient was treated with _" ] using kaletra
MBL @245 (98.4%) on 28-apr-2011 [ Promotion of archaea:kaletra drugworkedonbyagent biotechcompany:abbot_laboratories ]
CPL @1112 (52.6%) on 19-jul-2018 [ "overdosage with _" "_ is highly protein" "Geriatric Use Clinical studies of _" "Patients taking _" "drug interactions between _" "inhibitors including _" "Use Clinical studies of _" "combination therapy including _" "patient was treated with _" "period patient was treated with _" "same period patient was treated with _" "Information Do not take _" ] using kaletra
SEAL @132 (99.2%) on 23-jul-2010 [ 1234567 ] using kaletra
CPL @1097 (97.0%) on 19-jan-2018 [ "drugs including _" "drugs such as _" "overdosage with _" "dose of _" "patients treated with _" "you are taking _" "inhibitors such as _" "drug called _" ] using kaletra
SEAL @556 (87.5%) on 22-apr-2012 [ 123 ] using (kaletra, abbott_laboratories)
CPL @1094 (75.0%) on 01-jan-2018 [ "arg2 discovered and developed arg1" "arg2 under the brand names arg1" ] using (kaletra, abbott)
CPL @1094 (93.8%) on 01-jan-2018 [ "arg2 sells as arg1" "arg2 holds the patent for arg1" "arg2 under the trade name arg1" "arg2 sells under the brand name arg1" ] using (kaletra, abbott_laboratories)
SEAL @241 (75.0%) on 22-apr-2011 [ 12 ] using (kaletra, abbott)
SEAL @556 (87.5%) on 22-apr-2012 [ 123 ] using (kaletra, abbott_laboratories)
CPL @1094 (75.0%) on 01-jan-2018 [ "arg2 discovered and developed arg1" "arg2 under the brand names arg1" ] using (kaletra, abbott)
CPL @1094 (93.8%) on 01-jan-2018 [ "arg2 sells as arg1" "arg2 holds the patent for arg1" "arg2 under the trade name arg1" "arg2 sells under the brand name arg1" ] using (kaletra, abbott_laboratories)
SEAL @241 (75.0%) on 22-apr-2011 [ 12 ] using (kaletra, abbott)